These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 20600880)
1. Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing rats. Tian W; Ying X; Du J; Guo J; Men Y; Zhang Y; Li RJ; Yao HJ; Lou JN; Zhang LR; Lu WL Eur J Pharm Sci; 2010 Oct; 41(2):232-43. PubMed ID: 20600880 [TBL] [Abstract][Full Text] [Related]
2. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals. Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115 [TBL] [Abstract][Full Text] [Related]
3. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. Ying X; Wen H; Lu WL; Du J; Guo J; Tian W; Men Y; Zhang Y; Li RJ; Yang TY; Shang DW; Lou JN; Zhang LR; Zhang Q J Control Release; 2010 Jan; 141(2):183-92. PubMed ID: 19799948 [TBL] [Abstract][Full Text] [Related]
4. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes. Gao JQ; Lv Q; Li LM; Tang XJ; Li FZ; Hu YL; Han M Biomaterials; 2013 Jul; 34(22):5628-39. PubMed ID: 23628475 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of sequential targeting of brain glioma for transferrin-modified cisplatin liposome. Lv Q; Li LM; Han M; Tang XJ; Yao JN; Ying XY; Li FZ; Gao JQ Int J Pharm; 2013 Feb; 444(1-2):1-9. PubMed ID: 23347891 [TBL] [Abstract][Full Text] [Related]
6. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands. Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462 [TBL] [Abstract][Full Text] [Related]
7. Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals. Qin Y; Chen H; Zhang Q; Wang X; Yuan W; Kuai R; Tang J; Zhang L; Zhang Z; Zhang Q; Liu J; He Q Int J Pharm; 2011 Nov; 420(2):304-12. PubMed ID: 21945185 [TBL] [Abstract][Full Text] [Related]
8. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas. Li Y; He H; Jia X; Lu WL; Lou J; Wei Y Biomaterials; 2012 May; 33(15):3899-908. PubMed ID: 22364698 [TBL] [Abstract][Full Text] [Related]
9. Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma. Li XY; Zhao Y; Sun MG; Shi JF; Ju RJ; Zhang CX; Li XT; Zhao WY; Mu LM; Zeng F; Lou JN; Lu WL Biomaterials; 2014 Jul; 35(21):5591-604. PubMed ID: 24726749 [TBL] [Abstract][Full Text] [Related]
10. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells. Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164 [TBL] [Abstract][Full Text] [Related]
11. Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma. Ju RJ; Zeng F; Liu L; Mu LM; Xie HJ; Zhao Y; Yan Y; Wu JS; Hu YJ; Lu WL Int J Nanomedicine; 2016; 11():1131-46. PubMed ID: 27042063 [TBL] [Abstract][Full Text] [Related]
12. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009 [TBL] [Abstract][Full Text] [Related]
13. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats. Erdlenbruch B; Jendrossek V; Kugler W; Eibl H; Lakomek M Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304 [TBL] [Abstract][Full Text] [Related]
14. A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatment. Zhang CX; Zhao WY; Liu L; Ju RJ; Mu LM; Zhao Y; Zeng F; Xie HJ; Yan Y; Lu WL Oncotarget; 2015 Oct; 6(32):32681-700. PubMed ID: 26418720 [TBL] [Abstract][Full Text] [Related]
15. Targeting vincristine plus tetrandrine liposomes modified with DSPE-PEG Song XL; Liu S; Jiang Y; Gu LY; Xiao Y; Wang X; Cheng L; Li XT Eur J Pharm Sci; 2017 Jan; 96():129-140. PubMed ID: 27644895 [TBL] [Abstract][Full Text] [Related]
16. Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas. Kong D; Hong W; Yu M; Li Y; Zheng Y; Ying X Int J Nanomedicine; 2022; 17():1087-1110. PubMed ID: 35313461 [TBL] [Abstract][Full Text] [Related]
17. Epirubicin-encapsulated long-circulating thermosensitive liposome improves pharmacokinetics and antitumor therapeutic efficacy in animals. Wu Y; Yang Y; Zhang FC; Wu C; Lü WL; Mei XG J Liposome Res; 2011 Sep; 21(3):221-8. PubMed ID: 20929434 [TBL] [Abstract][Full Text] [Related]
18. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations. Liu G; Shen H; Mao J; Zhang L; Jiang Z; Sun T; Lan Q; Zhang Z ACS Appl Mater Interfaces; 2013 Aug; 5(15):6909-14. PubMed ID: 23883622 [TBL] [Abstract][Full Text] [Related]
19. [Basic studies on chemotherapy of brain tumors by means of liposomes: affinity of sulfatide-inserted liposomes to human glioma cells]. Kito A; Yoshida J; Kageyama N; Inoue I; Abe H; Arichi S; Kojima N; Yagi K No To Shinkei; 1987 Aug; 39(8):783-8. PubMed ID: 3426863 [TBL] [Abstract][Full Text] [Related]
20. Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals. Zong T; Mei L; Gao H; Cai W; Zhu P; Shi K; Chen J; Wang Y; Gao F; He Q Mol Pharm; 2014 Jul; 11(7):2346-57. PubMed ID: 24893333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]